V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310004288 | 310001858 | 1.6 | 72.7 | Curative (C) | 2016-09-30 | 2016-10-01 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 310019585 | NOT MATCHED |
| 310004289 | 310001859 | 1.83 | 82.5 | Curative (C) | null | 2017-04-22 | Rituximab | N | N | 310019587 | GEMCITABINE + PACLITAXEL |
| 310004290 | 310001860 | null | null | Disease modification (D) | null | 2017-01-16 | GEM-P | null | null | 310019588 | IMATINIB |
| 310004291 | 310001861 | null | 66 | null | null | 2015-11-17 | Gemcitabine weekly | N | N | 310019589 | GEMCITABINE |
| 310004292 | 310001862 | 1.76 | 76.1 | Curative (C) | 2013-12-25 | 2013-12-26 | null | 02 | N | 310019590 | NOT MATCHED |
| 310004293 | 310001863 | 1.58 | 48.1 | Curative (C) | 2013-10-26 | 2013-10-31 | GEM-P | N | N | 310019591 | RITUXIMAB |
| 310004294 | 310001864 | 1.7 | 66.8 | Palliative (P) | 2015-11-06 | 2015-11-19 | null | N | Y | 310019592 | NOT MATCHED |
| 310004295 | 310006796 | null | null | Palliative (P) | null | 2017-05-04 | Bexarotene | N | null | 310019593 | CAPECITABINE + CISPLATIN |
| 310004296 | 310006796 | null | 80.6 | Palliative (P) | 2017-03-29 | 2017-03-29 | IMATINIB | 2 | N | 310019593 | PACLITAXEL |
| 310004297 | 310006796 | null | 70 | Palliative (P) | 2014-10-08 | 2014-10-30 | Dacarbazine | null | N | 310019593 | CISPLATIN + FLUOROURACIL |
| 310004298 | 310001865 | 1.66 | 63 | Palliative (P) | 2015-07-11 | 2015-07-18 | Hydroxycarbamide | N | N | 310019596 | CAPECITABINE + OXALIPLATIN |
| 310004299 | 310006797 | null | 46 | Palliative (P) | 2016-11-01 | 2016-11-01 | Cisplatin +Fluorouracil (3 wk) | null | Y | 310019597 | HYDROXYCARBAMIDE |
| 310004300 | 310006797 | 1.86 | 72 | null | 2013-05-22 | 2013-05-22 | CISPLATIN + FLUOROURACIL | 02 | N | 310019597 | DACARBAZINE |
| 310004301 | 310006797 | 1.88 | 97 | null | 2015-05-31 | 2015-06-26 | Capecitabine + Cisplatin | N | N | 310019597 | EOX |
| 310004302 | 310006797 | 1.78 | null | Palliative (P) | 2018-06-21 | 2018-06-28 | Mitomycin Intravesical | N | N | 310019597 | RITUXIMAB |
| 310004303 | 310001866 | 1.68 | 55 | Disease modification (D) | 2014-08-14 | 2014-08-15 | ICON8 TRIAL | N | N | 310019603 | DACARBAZINE |
| 310004304 | 310001867 | null | 78.6 | null | 2014-08-18 | 2014-09-09 | Dacarbazine | N | N | 310019604 | EOX |
| 310004305 | 310001868 | null | 10.1 | Palliative (P) | 2018-03-25 | 2018-03-31 | Capecitabine | N | N | 310019607 | PACLITAXEL |
| 310004308 | 310009163 | 1.65 | 50 | Palliative (P) | 2016-11-26 | 2017-03-05 | IPILIMUMAB + NIVOLUMAB | null | null | 310019610 | IPILIMUMAB + NIVOLUMAB |
| 310004309 | 310009163 | 1.55 | 58 | Neo-adjuvant (N) | null | 2014-08-27 | Vemurafenib | 02 | N | 310019610 | LIPOSOMAL DOXORUBICIN |
| 310004310 | 310001870 | 1.69 | 0 | Adjuvant (A) | 2016-09-05 | 2016-09-11 | Capecitabine + Oxaliplatin 21day | N | N | 310019614 | IMATINIB |
| 310004311 | 310006799 | 1.96 | 70.4 | Curative (C) | 2015-05-17 | 2015-05-19 | null | N | N | 310019617 | NOT MATCHED |
| 310004312 | 310001871 | 1.66 | 59 | Palliative (P) | 2014-02-22 | 2014-02-22 | BCG Intravesical | 2 | N | 310019618 | BCG |
| 310004313 | 310001871 | null | null | null | 2015-11-14 | 2015-11-29 | Liposomal Doxorubicin (Caelyx) | N | N | 310019618 | IMATINIB |
| 310004314 | 310001872 | 1.69 | null | Palliative (P) | 2014-04-24 | 2014-04-24 | CAPECITABINE + OXALIPLATIN | 02 | N | 310019620 | BCG |
| 310004315 | 310001873 | 1.19 | null | Curative (C) | 2016-04-12 | 2016-04-13 | CHOEP | 02 | N | 310019623 | CHOEP |
| 310004316 | 310001874 | null | 65.7 | Palliative (P) | null | 2014-05-06 | IPILIMUMAB + NIVOLUMAB | N | N | 310019624 | IPILIMUMAB + NIVOLUMAB |
| 310004317 | 310001874 | 0 | 55.6 | Palliative (P) | 2016-07-03 | 2016-07-10 | BEVACIZUMAB + CARBO + PACLITAXEL | null | null | 310019624 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004318 | 310001875 | 1.72 | 72.15 | Palliative (P) | 2016-10-31 | 2017-05-17 | Liposomal Doxorubicin 50mg/m2 | N | N | 310019629 | VEMURAFENIB |
| 310004319 | 310001876 | null | null | Palliative (P) | 2013-06-14 | 2013-06-28 | Imatinib 400mg | N | N | 310019631 | RITUXIMAB |
| 310004320 | 310001877 | 1.62 | 0 | Curative (C) | 2013-12-12 | 2013-12-15 | CHOEP - 21 days | N | N | 310019632 | CHOEP |
| 310004321 | 310001878 | 1.74 | 75.5 | Palliative (P) | 2018-04-22 | 2018-04-25 | Oxaliplatin + Modified de Gramont | 02 | null | 310019634 | CISPLATIN + FLUOROURACIL |
| 310004322 | 310001878 | 0 | 79 | Palliative (P) | null | 2016-07-02 | Oxaliplatin + Modified de Gramont | N | N | 310019634 | HYDROXYCARBAMIDE |
| 310004323 | 310001878 | null | 89.65 | Disease modification (D) | 2016-08-24 | 2016-08-26 | IMATINIB | 02 | Y | 310019634 | LIPOSOMAL DOXORUBICIN |
| 310004324 | 310001878 | null | 70.4 | Disease modification (D) | 2017-11-02 | 2017-11-05 | CAPECITABINE + OXALIPLATIN | N | null | 310019634 | EOX |
| 310004325 | 310001878 | 1.63 | 78 | Curative (C) | 2016-10-02 | 2016-10-02 | ICON8 TRIAL | N | N | 310019634 | VEMURAFENIB |
| 310004326 | 310011459 | 1.85 | null | Curative (C) | 2016-07-07 | 2016-07-11 | Capecitabine + Oxaliplatin 14day | 2 | N | 310019642 | GEMCITABINE + PACLITAXEL |
| 310004327 | 310011459 | 0 | null | Palliative (P) | null | 2013-08-15 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 310019642 | CAPECITABINE + OXALIPLATIN |
| 310004328 | 310011459 | 1.58 | 70.4 | Palliative (P) | 2016-07-01 | 2016-07-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310019642 | CISPLATIN + ETOPOSIDE |
| 310004332 | 310001880 | null | 84.9 | Palliative (P) | 2015-07-10 | 2015-07-10 | Hydroxycarbamide | N | N | 310019659 | LIPOSOMAL DOXORUBICIN |
| 310004333 | 310001881 | 1.62 | 80.9 | Palliative (P) | 2015-03-07 | 2015-04-01 | Mitomycin Intravesical | N | N | 310019661 | CISPLATIN + ETOPOSIDE |
| 310004334 | 310001881 | 1.72 | null | Curative (C) | 2016-09-14 | 2016-09-22 | CHOEP - 21 days | N | N | 310019661 | CHOEP |
| 310004335 | 310001881 | 1.71 | 20 | Palliative (P) | null | 2016-10-11 | IPILIMUMAB + NIVOLUMAB | null | null | 310019661 | IPILIMUMAB + NIVOLUMAB |
| 310004336 | 310001882 | null | null | null | 2013-03-28 | 2013-03-30 | CISPLATIN + FLUOROURACIL | 02 | N | 310019666 | CISPLATIN + ETOPOSIDE |
| 310004337 | 310006805 | 1.65 | 0 | Palliative (P) | 2014-10-30 | 2014-11-11 | ECX | N | N | 310019667 | ECX |
| 310004338 | 310006805 | 1.73 | 30 | Curative (C) | 2014-05-29 | 2014-05-30 | null | N | Y | 310019667 | NOT MATCHED |
| 310004339 | 310001883 | 1.71 | 0 | Palliative (P) | 2016-09-13 | 2016-09-13 | IPILIMUMAB + NIVOLUMAB | N | N | 310019672 | IPILIMUMAB + NIVOLUMAB |
| 310004340 | 310001884 | 2 | 84.7 | Neo-adjuvant (N) | 2018-01-07 | 2018-01-27 | ECX | N | N | 310019673 | ECX |
| 310004341 | 310001884 | 1.46 | 13 | Curative (C) | 2014-09-12 | 2014-09-16 | Retinoblastoma Rel | 02 | N | 310019673 | NOT MATCHED |
| 310004342 | 310001884 | 0 | 94.2 | Palliative (P) | 2014-12-23 | 2014-12-26 | IPILIMUMAB + NIVOLUMAB | N | N | 310019673 | IPILIMUMAB + NIVOLUMAB |